Trading-Stocks.de

Normale Version: NeoGenomics
Du siehst gerade eine vereinfachte Darstellung unserer Inhalte. Normale Ansicht mit richtiger Formatierung.
NeoGenomics (NEO) Meets Q2 Earnings Estimates


NeoGenomics (NEO - Free Report) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.

A quarter ago, it was expected that this operator of cancer-focused testing laboratories would post earnings of $0.05 per share when it actually produced earnings of $0.07, delivering a surprise of 40%.

Over the last four quarters, the company has surpassed consensus EPS estimates three time
.........................



http://www.zacks.com/stock/news/453508/n...-estimates?






[Bild: NEOc1dl1028.png]